BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma

Journal of Urology

Volumn 191, Issue 3, 2014, Pages 603-610

  Kapur, Payal ^a   Christie, Alana ^k   Raman, Jay D ^d   Then, Matthew T ^e   Nuhn, Philipp ^f   Buchner, Alexander ^f   Bastian, Patrick ^g   Seitz, Christian ^h,i   Shariat, Shahrokh F ⁱ   Bensalah, Karim ^j   Rioux Leclercq, Nathalie ^j   Xie, Xian Jin ^c   Lotan, Yair ^a   Margulis, Vitaly ^a   Brugarolas, James ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

^g Paracelsus Klinik Golzheim   (Germany)

^h CENTRAL HOSPITAL OF BOLZANO   (Italy)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITÉ DE RENNES 1   (France)

^k NONE

more..

Author keywords

BAP1 protein; carcinoma; human; kidney; prognosis; renal cell; risk

Indexed keywords

BAP1 PROTEIN; CARCINOMA; HUMAN; KIDNEY; PROGNOSIS; RENAL CELL; RISK;

AGED; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84893845225     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.09.041     Document Type: Article

References (25)

1. R.J. Motzer, B. Escudier, and S. Oudard et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors Cancer 116 2010 4256
2. A. Zisman, A.J. Pantuck, and J. Wieder et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559
3. I. Frank, M.L. Blute, and J.C. Cheville et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol 168 2002 2395
4. M. Sorbellini, M.W. Kattan, and M.E. Snyder et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma J Urol 173 2005 48
5. M.H. Tan, H. Li, and C.V. Choong et al. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma Cancer 117 2011 5314
6. R. Zigeuner, G. Hutterer, and T. Chromecki et al. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology Eur Urol 57 2010 102
7. P.I. Karakiewicz, A. Briganti, and F.K. Chun et al. Multi-institutional validation of a new renal cancer-specific survival nomogram J Clin Oncol 25 2007 1316
8. V. Ficarra, M. Brunelli, and G. Novara et al. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours Pathology 43 2011 149
9. S. Peña-Llopis, S. Vega-Rubin-de-Celis, and A. Liao et al. BAP1 loss defines a new class of renal cell carcinoma Nat Genet 44 2012 751
10. A.A. Hakimi, I. Ostrovnaya, and B.A. Reva et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network Clin Cancer Res 19 2013 3259
11. Cancer Genome Atlas Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43
12. I. Varela, P. Tarpey, and K. Raine et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539
13. G. Guo, Y. Gui, and S. Gao et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma Nat Genet 44 2012 17
14. G.L. Dalgliesh, K. Furge, and C. Greenman et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360
15. P. Kapur, S. Pena-Llopis, and A. Christie et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation Lancet Oncol 14 2013 159
16. P. Kapur, A. Christie, and S. Peña-Llopis et al. BAP1 loss defines a pathologically aggressive subgroup of clear cell renal cell carcinoma Mod Pathol 26 2013 223A
17. A.A. Hakimi, Y.B. Chen, and J. Wren et al. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma Eur Urol 63 2013 848
18. Y. Sato, T. Yoshizato, and Y. Shiraishi et al. Integrated molecular analysis of clear-cell renal cell carcinoma Nat Genet 45 2013 860
19. J.N. Eble World Health Organization: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon 359
20. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655
21. Edge SB, Byrd DR, Compton CC, et al. AJCC Staging Manual, 7th ed. Philadelphia: Springer 2009.
22. O.M. Darwish, P. Kapur, and R.F. Youssef et al. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma Urology 81 2013 581
23. S.R. Cole, and M.A. Hernan Adjusted survival curves with inverse probability weights Comput Methods Programs Biomed 75 2004 45
24. M. Gerlinger, A.J. Rowan, and S. Horswell et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883
25. K. Barwari, J.J. de la Rosette, and M.P. Laguna The penetration of renal mass biopsy in daily practice: a survey among urologists J Endourol 26 2012 737